<code id='33197B8863'></code><style id='33197B8863'></style>
    • <acronym id='33197B8863'></acronym>
      <center id='33197B8863'><center id='33197B8863'><tfoot id='33197B8863'></tfoot></center><abbr id='33197B8863'><dir id='33197B8863'><tfoot id='33197B8863'></tfoot><noframes id='33197B8863'>

    • <optgroup id='33197B8863'><strike id='33197B8863'><sup id='33197B8863'></sup></strike><code id='33197B8863'></code></optgroup>
        1. <b id='33197B8863'><label id='33197B8863'><select id='33197B8863'><dt id='33197B8863'><span id='33197B8863'></span></dt></select></label></b><u id='33197B8863'></u>
          <i id='33197B8863'><strike id='33197B8863'><tt id='33197B8863'><pre id='33197B8863'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:988
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Drinking water from half of US faucets contains PFAS: Study
          Drinking water from half of US faucets contains PFAS: Study

          CoryMorse/TheGrandRapidsPressviaAPDrinkingwaterfromnearlyhalfofU.S.faucetslikelycontains“foreverchem

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          The world needs the new pandemic treaty

          AdobeAttheheightoftheCovid-19pandemic,25headsofgovernmentissuedanextraordinarycallforanewinternation